Grade: B — Generally Healthy, Insurance Accounting Complexity
Framework: Life insurance-specific analysis + Schilit principles (traditional checks partially N/A for insurers)
Data: SEC EDGAR 10-K (Filed 2026-02-19) + Yahoo Finance
Auditor: Deloitte & Touche LLP — Clean opinion
One-line verdict: MetLife reported net income of $3.38 billion ($3,173 million available to common shareholders) on total revenues of $77.1 billion in 2025. Net income declined 24% from $4.43 billion in 2024, primarily due to higher net derivative losses ($1.94 billion vs. $1.62 billion), larger net investment losses ($1.15 billion), and a higher effective tax rate. But the core insurance operations remain solid — premiums grew 11% to $49.8 billion, net investment income held steady at $22.6 billion, and policyholder benefits tracked premium growth. Cash flow conversion is excellent: CFFO/NI of 5.06x (insurance companies collect premiums far ahead of claim payments). The screening engine flags DSO as surging 82 days and AR growth significantly exceeding revenue growth — these are artifacts of insurance accounting where "receivables" include reinsurance recoverables and policy-related balances, not commercial AR. The real risks are derivative losses, the complexity of LDTI (Long-Duration Targeted Improvements) accounting, and the sheer opacity of a $700+ billion balance sheet.
| Metric | Result |
|---|---|
| Red Flags (Engine) | **1** (A1 — DSO surge, structural for insurance) |
| Watch Items | **2** (A2, D1) |
| Checks Completed | **11/18** (7 N/A — not applicable to insurance) |
| Beneish M-Score | **N/A** (not applicable to insurance companies) |
| F-Score (Fraud Probability) | **1.60** (0.59% probability) |
| Altman Z-Score | **N/A** (not applicable to insurance companies) |
| Auditor | Deloitte & Touche LLP — Unqualified opinion |
| Fiscal Year | 2025 (ended December 31, 2025) |
| Report Date | 2026-04-05 |
Important note on financial companies: The Beneish M-Score and Altman Z-Score were designed for manufacturing and commercial enterprises and are not applicable to life insurance companies. Insurance earnings quality must be assessed through premium growth, investment income stability, reserve adequacy, derivative hedging effectiveness, and capital strength.
Consolidated Results: Premiums Grow, NI Declines
Per the 10-K Consolidated Results:
| Metric | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Premiums | $44,283M | $44,945M | **$49,779M** | +10.8% |
| Net Investment Income | $19,908M | $21,273M | **$22,559M** | +6.0% |
| Net Investment Gains (Losses) | ($2,824M) | ($1,184M) | **($1,145M)** | Improving |
| Net Derivative Gains (Losses) | ($2,140M) | ($1,623M) | **($1,939M)** | Worsening |
| Total Revenues | $66,905M | $70,986M | **$77,084M** | +8.6% |
| Total Expenses | $64,743M | $65,364M | **$72,423M** | +10.8% |
| Income Before Tax | $2,162M | $5,622M | **$4,661M** | -17.1% |
| Net Income to MetLife | $1,578M | $4,426M | **$3,379M** | -23.6% |
| Net Income to Common | $1,380M | $4,226M | **$3,173M** | -24.9% |
The 24% decline in net income was driven by three factors:
The underlying insurance operations (premiums + investment income) grew, but mark-to-market items created GAAP headwinds.
Investment Income: The Earnings Anchor
Per the 10-K: Net investment income of $22.6 billion grew 6% and represents the stable foundation of MetLife's earnings. This includes income from a general account investment portfolio of approximately $400+ billion in fixed maturity securities, mortgage loans, and alternative investments.
Policyholder benefits and claims of $50.3 billion tracked premium growth at 11%. The 10-K notes policyholder liability remeasurement gains of $150 million in 2025 (vs. gains of $206 million in 2024), indicating reserves are adequate.
Cash Flow Quality: Structurally Strong
Per the screening engine:
| Cash Flow Metric | Value |
|---|---|
| CFFO/NI | 5.06x |
| FCF | $17.1B |
| FCF/NI | 5.06x |
| Accruals Ratio | -1.8% |
The 5.06x CFFO/NI ratio is not an anomaly — it is structural for insurance companies. Insurers collect premiums upfront and pay claims over many years (especially life insurance). The resulting operating cash flow far exceeds net income. This is a positive indicator of insurance company health, not a red flag.
Balance Sheet: Insurance Scale
Per the screening results:
| Item | Value |
|---|---|
| Cash + Investments | $118.3B |
| Total Debt | $20.2B |
| Cash/Debt | Coverage adequate |
| Goodwill + Intangibles | $9.6B (34% of equity) |
Goodwill plus intangibles at 34% of equity is moderate and within acceptable range. The 8% growth in goodwill and intangibles year-over-year reflects minor acquisition activity.
MetLife's total assets exceed $700 billion, dominated by investments backing policyholder obligations. The complexity of this balance sheet — including future policy benefits, policyholder account balances, market risk benefits, and derivative positions — makes traditional balance sheet analysis challenging.
The 18-Point Screening
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | **FAIL*** | DSO surged 82 days (155 to 237). *Insurance accounting artifact |
| A2 | AR vs Revenue Growth | WATCH* | AR growth 64.8% vs revenue 7.9%. *Insurance accounting artifact |
| A3 | Revenue vs CFFO | PASS | Revenue +7.9%, CFFO +17.1% |
| B1 | Inventory vs COGS | PASS | No material inventory |
| B2 | CapEx vs Revenue | N/A | Insufficient data |
| B3 | SG&A Ratio | N/A | Not applicable to insurance |
| B4 | Gross Margin | N/A | Not applicable to insurance |
| C1 | CFFO vs Net Income | PASS | CFFO/NI = 5.06 (structural for insurance) |
| C2 | Free Cash Flow | PASS | FCF $17.1B, FCF/NI = 5.06 |
| C3 | Accruals Ratio | PASS | -1.8%. Low accruals |
| C4 | Cash vs Debt | PASS | Cash $118.3B covers debt $20.2B |
| D1 | Goodwill + Intangibles | WATCH | $9.6B = 34% of equity |
| D2 | Leverage | N/A | Not applicable to insurance |
| D3 | Soft Asset Growth | N/A | Not applicable to insurance |
| D4 | Asset Impairment | N/A | No write-off data |
| E1 | Serial Acquirer FCF | PASS | FCF after acquisitions positive |
| E2 | Goodwill Surge | PASS | Goodwill change +8% YoY |
| F1 | Beneish M-Score | N/A | Not applicable to insurance |
*The A1 and A2 flags are structural false positives for insurance companies. Insurance "receivables" include reinsurance recoverables, accrued investment income, and policy-related balances — not commercial accounts receivable. Changes in these balances reflect business growth and reinsurance timing, not revenue recognition issues.
Key Risks from the 10-K
1. Derivative Losses Volatility
Net derivative losses of $1.94 billion in 2025 represent hedging costs to protect the investment portfolio and policyholder liabilities. While these hedges serve a protective purpose, the GAAP impact creates significant earnings volatility and can mask underlying performance.
2. LDTI Accounting Complexity
The Long-Duration Targeted Improvements (LDTI) standard, which MetLife adopted, requires regular reassessment of assumptions used to measure future policy benefits. The resulting remeasurement gains and losses flow through income, creating additional volatility.
3. Investment Portfolio Credit Risk
The 10-K notes net investment losses of $1.15 billion. With a massive general account investment portfolio, credit defaults, downgrades, or mark-to-market losses on fixed-income holdings could materially impact results.
4. Catastrophe and Mortality Risk
As a life and property insurer, MetLife is exposed to mortality events, natural catastrophes, and pandemic risk that could cause sudden spikes in claims.
Summary
Grade: B. Generally healthy. Strong insurance operations with GAAP earnings volatility from derivatives and accounting standards.
MetLife's core insurance business is performing well — premiums grew 11%, net investment income grew 6%, and cash flow conversion is structurally strong at 5.06x net income. The decline in net income is driven by derivative hedging costs and mark-to-market items, not operational deterioration.
The key considerations:
The screening engine flags (A1, A2) are structural false positives for insurance companies and do not indicate earnings quality concerns.
**Disclaimer**: This report is based on MetLife's fiscal year 2025 10-K filed with the SEC on February 19, 2026. This is NOT investment advice.
**About EarningsGrade**: We screen earnings reports for financial red flags using an 18-point forensic framework. Grade B means the company is generally healthy with minor concerns to monitor.
